Across the recent three months, 4 analysts have shared their insights on Generation Bio (NASDAQ:GBIO), expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent ...
Generation Bio is shedding 90% of its workforce after the biotech acknowledged it’s unlikely to find the cash to take its lipid nanoparticle tech into the clinic. The Massachusetts-based company has ...
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune ...
CAMBRIDGE, Mass., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co (GBIO). (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback